GERD (GASTROESOPHAGEAL REFLUX DISEASE)
Clinical trials for GERD (GASTROESOPHAGEAL REFLUX DISEASE) explained in plain language.
Never miss a new study
Get alerted when new GERD (GASTROESOPHAGEAL REFLUX DISEASE) trials appear
Sign up with your email to follow new studies for GERD (GASTROESOPHAGEAL REFLUX DISEASE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Breakfast vs. pill: new study tests GERD drug timing
Knowledge-focused CompletedThis early-stage trial looked at how taking a new GERD drug (DW4421) with or without food changes its safety and levels in the body. Twenty-four healthy adults took the drug by mouth, and researchers measured peak concentration and total exposure over time. The goal was to gather…
Matched conditions: GERD (GASTROESOPHAGEAL REFLUX DISEASE)
Phase: PHASE1 • Sponsor: Daewon Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated May 26, 2026 10:21 UTC
-
Healthy volunteers test drug interaction in Early-Stage trial
Knowledge-focused CompletedThis early-stage trial looked at how a new medicine for acid reflux (linaprazan glurate) affects the way the body processes the common antibiotic amoxicillin. Twelve healthy adults took both drugs and had their blood levels measured. The goal was to gather safety and drug interac…
Matched conditions: GERD (GASTROESOPHAGEAL REFLUX DISEASE)
Phase: PHASE1 • Sponsor: Cinclus Pharma Holding AB • Aim: Knowledge-focused
Last updated May 26, 2026 10:15 UTC